Cargando…
Immunotherapy in Breast Cancer and the Potential Role of Liquid Biopsy
Liquid biopsy biomarkers, such as circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA), are noninvasive diagnostics that could complement predictive and prognostic tools currently used in the clinic. Recent trials of immunotherapy have shown promise in improving outcomes in a subset of b...
Autores principales: | Magbanua, Mark Jesus M., Gumusay, Ozge, Kurzrock, Razelle, van ‘t Veer, Laura J., Rugo, Hope S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964955/ https://www.ncbi.nlm.nih.gov/pubmed/35372077 http://dx.doi.org/10.3389/fonc.2022.802579 |
Ejemplares similares
-
Emerging treatment strategies for metastatic triple-negative breast cancer
por: Huppert, Laura A., et al.
Publicado: (2022) -
The role of percutaneous vertebral augmentation in patients with metastatic breast cancer: Literature review including report of two cases
por: Gumusay, Ozge, et al.
Publicado: (2022) -
Case Report: Early detection of pancreatic pre-cancer lesion in multimodal approach with exosome liquid biopsy
por: Dhani, Harmeet, et al.
Publicado: (2023) -
Immunotherapy toxicity: identification and management
por: Gumusay, O., et al.
Publicado: (2022) -
Liquid biopsy: current technology and clinical applications
por: Nikanjam, Mina, et al.
Publicado: (2022)